Meeting Review: The management of multiple sclerosis in children: a European view

Real-life impact of early interferonβ therapy in relapsing multiple sclerosis

(2009) M. Trojano et al.   ANNALS OF NEUROLOGY

Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: A meta-analytic approach

(2009) Maria Pia Sormani et al.   ANNALS OF NEUROLOGY

Difference in Disease Burden and Activity in Pediatric Patients on Brain Magnetic Resonance Imaging at Time of Multiple Sclerosis Onset vs Adults

(2009) Emmanuelle Waubant et al.   ARCHIVES OF NEUROLOGY

Increased Relapse Rate in Pediatric-Onset Compared With Adult-Onset Multiple Sclerosis

(2009) Mark P. Gorman et al.   ARCHIVES OF NEUROLOGY

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial

(2009) G Comi et al.   LANCET

Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study

(2009) Eva Havrdova et al.   LANCET NEUROLOGY

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial

(2009) Ludwig Kappos et al.   LANCET NEUROLOGY

Therapy-related acute leukaemia with Mitoxantrone: what is the risk and can we minimise it?

(2009) R Ellis et al.   Multiple Sclerosis Journal

Measures in the first year of therapy predict the response to interferon β in MS

(2009) J Río et al.   Multiple Sclerosis Journal

Long-term results of immunomodulatory treatment in children and adolescents with multiple sclerosis: the Italian experience

(2009) Angelo Ghezzi et al.   NEUROLOGICAL SCIENCES

Cyclophosphamide therapy in pediatric multiple sclerosis

(2009) N. Makhani et al.   NEUROLOGY

Vasculitis in Children and Adolescents

(2009) Kjell Tullus et al.   PEDIATRIC DRUGS

Natalizumab Use in Pediatric Multiple Sclerosis

(2008) Peter Huppke et al.   ARCHIVES OF NEUROLOGY

EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases

(2008) I. Elovaara et al.   EUROPEAN JOURNAL OF NEUROLOGY

Effectiveness of early beta interferon on the first attack after confirmed multiple sclerosis: A comparative cohort study

(2008) Yann Mikaeloff et al.   EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY

Natalizumab treatment in pediatric multiple sclerosis: A case report

(2008) Giovanna Borriello et al.   EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY

Relationship between MRI lesion activity and response to IFN-β in relapsing–remitting multiple sclerosis patients

(2008) J Río et al.   Multiple Sclerosis Journal

Glatiramer acetate is a treatment option in neutralising antibodies to interferon-beta-positive patients

(2008) Marco Capobianco et al.   NEUROLOGICAL SCIENCES

Ethics of placebo-controlled clinical trials in multiple sclerosis: A reassessment

(2008) C. H. Polman et al.   NEUROLOGY

Predictive markers for response to interferon therapy in patients with multiple sclerosis

(2008) S. Malucchi et al.   NEUROLOGY

Cognitive and psychosocial features of childhood and juvenile MS

(2008) M. P. Amato et al.   NEUROLOGY

Vanishing MS T2-bright lesions before puberty: A distinct MRI phenotype?

(2008) D. Chabas et al.   NEUROLOGY